GS-4774: Phase II data

Top-line data from the open-label, U.S. and New Zealand Phase II GS-US-330-0101 trial in 178 virally suppressed patients with chronic HBV infection showed that 40 yeast units of subcutaneous GS-4774 once

Read the full 312 word article

How to gain access

Continue reading with a
two-week free trial.